Table 1.
Distribution of GI pathogens (mono-infection and co-infections) relative to the patients’ age groups
| GI Pathogens | Age (year) groups | Total | P-value | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||
| 0–4 (n=36) | 5–19 (n=40) | 20–40 (n=48) | >40 (n=39) | |||||||||
|
|
|
|
|
|
||||||||
| Mono- | Co- | Mono- | Co- | Mono- | Co- | Mono- | Co- | Mono- | Co- | Total | ||
| G. duodenalis | 9 | 3 | 5 | 3 | 2 | 2 | 2 | 1 | 18 | 9 | 27 | 0.006 sig |
|
| ||||||||||||
| Cryptosporidium | 6 | 1 | 4 | 0 | 1 | 1 | 1 | 0 | 12 | 2 | 14 | 0.036 sig |
|
| ||||||||||||
| E. histolytica | 0 | 0 | 1 | 0 | 2 | 0 | 1 | 0 | 4 | 0 | 4 | 0.463 |
|
| ||||||||||||
| Salmonella | 0 | 0 | 0 | 1 | 2 | 0 | 2 | 0 | 4 | 1 | 5 | 0.673 |
|
| ||||||||||||
| Shigella | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 2 | 2 | 0.273 |
|
| ||||||||||||
| E. coli 0157 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 3 | 3 | 0.173 |
|
| ||||||||||||
| STEC | 0 | 0 | 1 | 2 | 0 | 1 | 0 | 1 | 1 | 4 | 5 | 0.683 |
|
| ||||||||||||
| ETEC | 0 | 0 | 0 | 1 | 0 | 3 | 0 | 0 | 0 | 4 | 4 | 0.463 |
|
| ||||||||||||
| Campylobacter | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 4 | 4 | 0.653 |
|
| ||||||||||||
| Rotavirus | 16 | 3 | 7 | 1 | 1 | 1 | 3 | 0 | 27 | 5 | 32 | <0.001 HS |
|
| ||||||||||||
| Adenovirus | 0 | 2 | 3 | 0 | 1 | 0 | 1 | 0 | 5 | 2 | 7 | 0.573 |
|
| ||||||||||||
| Total | 31 | 10 | 21 | 11 | 9 | 11 | 10 | 4 | 71 | 36a | 107 | 0.930 |
G. duodenalis, Giardia duodenalis; E. coli 0157, Escherichia coli O157; STEC, Shiga-like toxin producing E. coli stx1/stx2; ETEC, Enterotoxigenic E. coli LT/ST; mono-, mono-infection; Co-, co-infections; sig, statistically-significant (the P-value was calculated according to the chi-square score); HS, highly significant.
a
Different enteropathogens were concomitantly diagnosed in just 16 episodes (12 as double infections and 4 as multiple infections).